Loading...

TC BIOPHARM (HOLDINGS) PLC Capital Structure Changes 8-K Filing

TC B

TC BIOPHARM (HOLDINGS) PLC

()

2024 8-K

Show Summary

Summary

AGM Results Summary

Annual Meeting Notice

Shareholder Meeting Update

General Meeting Notice

Nasdaq Delisting Notice

ADS Ratio Change

Special Dividend Announcement

Nasdaq Delisting Notice

Special Dividend Approved

Shareholder Meeting Results

Share Offering Agreement

Shareholder Meeting Notice

Financial Filing Update

Management Compensation Cha...

New Securities Offering

Regained Compliance

Equity Offering Completed

ADS Ratio Change

Nasdaq Compliance Update

Annual Meeting Results

Home Country Exemption

Notice of Delisting or Fail...

Compliance with Minimum Sto...

Agreement with Existing War...

Acquisition of Assets

Shareholder Meeting

Equity Issuance

Departure of CEO and Compen...

Options Grant and Cancellation

Shareholder Update and Prox...

External Links:

TC BioPharm (Holdings) PLC issued a shareholder update via press release and filed a preliminary proxy statement with the SEC regarding a general meeting of shareholders to obtain approval for the proposed sale or issuance of shares at a price lower than the closing price.

AI Assistant

TC BIOPHARM (HOLDINGS) PLC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.